ZOMANEX
Transforming Class II (eg. Gleevec) and Class IV (eg. Paclitaxel) drugs to novel oral delivery using our patented ORAZOM platform technology.
- Stage Prototype Ready
- Industry Biotechnology
- Location Vancouver, BC, Canada
- Currency USD
- Founded August 2017
- Employees 2
- Incorporation Type C-corp
- Website zomanex.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.